Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Acetoacetate-preconditioned adipose stem cells promote burn wound healing through enhanced cellular retention and paracrine signaling.

Hu Z., Huang J., Chen S., Xie JL., Jia S., Zhao C.

Animal Study on Chronic Wound, Burns, published in Burns (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Burns (2026)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
41621258
DOI
10.1016/j.burns.2026.107873

Abstract (original English)

Background In this study, we preconditioned human adipose-derived stem cells (ADSCs) with acetoacetate (AcAc) and explored whether it could improve cell survival and enhance the tissue regeneration of chemical burns in mice. Methods To evaluate the therapeutic efficacy of AcAc, human ADSCs were preconditioned with 10 mM AcAc (AcAc-hADSCs). Cell proliferation, migration, paracrine release of growth factors, and proangiogenic effects of AcAc-hADSCs were subsequently assessed. Subsequently, HCl acid burns were induced on the dorsal skin of ICR mice, and wound healing progression was monitored through macroscopic examination. The wounds were harvested for histological assessment via staining. Angiogenesis in wounds was detected via immunohistochemical staining. hADSCs were prelabeled with DiO, and their wound survival was detected via an in vivo bioluminescence imaging system. Results Pretreatment with AcAc enhanced the migration of ADSCs and the paracrine release of proangiogenic cytokines, including HIF-1α, VEGFA, HGF, FGF-2 and TGF-β, and increased the expression of SOD1. Compared with those treated with control hADSCs, the wounds that received AcAc-hADSCs presented accelerated re-epithelialization, increased extracellular matrix (ECM) deposition, and improved the microvessel density by HIF-1α-VEGFA pathway. Moreover, the DiO-labelled AcAc-hADSCs could be observed even after 72

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsWound HealingMiceCell ProliferationCell MovementHumansParacrine CommunicationMice, Inbred ICRMaleAcetoacetates

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research